BYND Cannasoft Releasing First-of-Its-Kind CRM Platform for $33B Medical Cannabis Market
BYND Cannasoft Enterprises Inc. (NASDAQ: $BCAN) Has Just Announced an Innovative New CRM Platform That Could Change the Game for the Legal Cannabis Industry. Plus, $BCAN is Already Showing a Similar Setup to Recent Picks $ATNF, $COSM & $APCX.
Medicinal cannabis
What You Should Know
The medical cannabis industry is a rapidly growing and evolving sector that involves the production and distribution of cannabis-based products for medicinal purposes. Medical cannabis refers to the use of cannabis and its derivatives to treat a variety of medical conditions, including chronic pain, epilepsy, multiple sclerosis, and Crohn's disease, among others.
This burgeoning industry has its roots in the increasing call to legalize cannabis for medicinal purposes, which began in the 1970s before really gaining momentum in the 1990s. Since then, many countries and states have passed laws to legalize medical cannabis (or even decriminalize cannabis altogether), allowing the cannabis industry to root.
One of the main drivers of the medical cannabis industry is the increasing recognition of the potential therapeutic benefits of cannabis. Research has shown that cannabis and its derivatives can be effective in treating a variety of medical conditions, and many people have turned to medical cannabis as a safer and more natural alternative to traditional pharmaceuticals.
The medical cannabis industry is regulated by governments, which set rules and guidelines for the production, distribution, and use of medical cannabis. These regulations vary widely from place to place, and they often reflect the local political and cultural attitudes towards cannabis.
The medical cannabis industry is a complex and multifaceted sector that involves a wide range of stakeholders, including patients, healthcare professionals, growers, manufacturers, distributors, and regulators. It is a rapidly evolving industry that is likely to continue to grow and change as more research is conducted and more countries and states legalize medical cannabis.
THE TRADE OPPORTUNITY
Why Invest in Medical Cannabis?
The medical cannabis industry is a rapidly growing and evolving sector that has the potential to offer attractive investment opportunities for those who are able to accurately predict and respond to industry trends and developments.
Growing Demand
The demand for medical cannabis is expected to continue to grow as more people turn to cannabis-based products as a treatment option for a variety of medical conditions. This trend is driven by the increasing recognition of the potential therapeutic benefits of cannabis and the growing movement to legalize cannabis for medicinal purposes.
Increasing Legalization
The increasing legalization of medical cannabis in countries and states around the world is expected to create new opportunities for businesses in the medical cannabis industry. As more people have access to cannabis-based products for medicinal purposes, the industry is likely to continue to grow and expand.
Strong Financial Performance
The financial performance of the medical cannabis industry has been strong in recent years, with many companies reporting significant revenues and profits. This trend is expected to continue as the industry grows and expands.
Technological Innovation
The medical cannabis industry is a rapidly evolving sector that is likely to be impacted by technological innovation. Companies that are able to develop and adopt new technologies and techniques may be well-positioned to take advantage of growth opportunities in the industry.
Social/Political Factors
The social and political landscape surrounding medical cannabis is complex and dynamic, and changes in public attitudes and policy can have a significant impact on the industry. Investors who are able to accurately predict and respond to changes in the social and political landscape may be able to capitalize on opportunities in the industry.
About BYND Cannasoft Enterprises Inc.
BYND owns and markets a proprietary customer relationship management (CRM) software product, known as “Benefit CRM”.
BYND has recently begun development of an entirely new, innovative CRM platform, designed specifically to serve the needs of the medical cannabis industry.
Cloud-based Benefit CRM software enables small and medium-sized businesses to optimize their day-to-day business activities, such as sales management, personnel management, marketing, call center activities, and asset management.
Now ready for BETA testing.
Building on 20 years of experience in CRM software, Cannabis CRM is a first-of-its-kind CRM platform designed to meet the needs of the medical cannabis industry. This new platform could turn the cannabis industry into a more organized, accessible, and price-transparent market.
What is a Customer Relationship Management (CRM) Platform?
Customer relationship management (CRM) software refers to platforms designed to help businesses manage and analyze customer interactions and data throughout the customer lifecycle. The goal of CRM software is to improve customer relationships and customer satisfaction, and ultimately to increase profits and sales.
CRM software typically includes a range of features and tools that are designed to help businesses manage customer interactions and data. These features may include contact management, sales tracking, customer service and support, marketing automation, and analytics and reporting.
CRM software is often used by sales, marketing, and customer service teams to manage customer interactions and data, and to analyze customer behavior and preferences. The software can be used to track customer interactions across various channels, including email, phone, social media, and in-person meetings, and to collect data about customer preferences, behaviors, and needs.
By using CRM software, businesses can improve customer relationships and customer satisfaction by providing personalized and targeted marketing and customer service, and by identifying and addressing customer needs and concerns in a timely and effective manner. Additionally, CRM software can help businesses to analyze customer data and trends, and to identify opportunities for growth and improvement.
BYND Cannasoft Announces Cloud-Baased SaaS CRM Platform
Building on 20 years of experience in CRM software, Cannabis CRM is a first-of-its-kind CRM platform designed to meet the needs of the medical cannabis industry. This new platform could turn the cannabis industry into a more organized, accessible, and price-transparent market.
BYND Cannasoft Enterprises Inc. Primed for Explosive Growth in the Next 12 Months
For 2023, BYND will focus their attention on several critical corporate milestones and benchmarks. The company will complete the patent registration and regulation of the various devices developed by BYND Cannasoft as well as completing the development of their much-heralded EZ-G device.
BYND will also complete the procedures for obtaining a license to trade in medical cannabis. The company looks to generate significant revenues and profits from the realization and completion of their production and distribution agreement with pharmacies in Israel.
Additionally, representatives of BYND Cannasoft have expressed the desire to expand their production and distribution by opening additional markets for their own medical cannabis products, mainly in the U.K. and Germany.
The company’s relationship with the Weizmann Institute remains strong.
In 2023, BYND intends to complete the beta version of the cannabis software and expand their R&D efforts. The company will continue to add value for stakeholders by locating companies synergistic with BYND Cannasoft and making significant investments to expand their growth-oriented activities.
Cannabis CRM is a First-of-Its-Kind CRM Platform Designed Specifically for the Medical Cannabis Industry
In the News
BYND Cannasoft Enterprises Inc. continues to take some major swings, both in the medical cannabis industry as well as in other industries. Here are some headlines you should know about.
Multinational BYND Cannasoft to Utilize Israeli License for Its EZ-G Smart Cartridges Using Artificial intelligence (AI) Software to Individualize Each Dose
March 1, 2023
Plans to formulate proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel in its AI based device and EZ-G device.
U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the Multibillion-Dollar Sextech Industry
March 8, 2023
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed US Provisional Patent Application 63/450,503 on March 7, 2023 covering the mechanical structure, operation, and controlling aspects of an additional smart female treatment device.
Israeli Cannabis Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device
January 17, 2023
The new full scale PCT application for the EZ-G device, comprised of a structure and one or more moving and vibrating elements, will utilize Artificial Intelligence (AI) to send data about learned sexual preferences to the cloud to heighten arousal, and intimacy.
Israel's Ministry of Health, through the Medical Cannabis Unit, announced today that it has granted BYND Cannasoft Enterprises Inc.'s Subsidiary, Cannasoft Pharma, a License
February 6, 2023
The Medical Cannabis Unit at the Ministry of Health of the State of Israel has provided a full license to engage in medical cannabis without direct contact with the substance that will allow trading in medical cannabis products through an agreement with a licensed cannabis grower in Israel.
CEO Writes Letter to Shareholders
December 15, 2022
BYND Cannasoft issued a letter to shareholders from its Chief Executive Officer and Director, Yftah Ben Yaackov.
Disrupting the Sex Toy Market
December 7, 2022
BYND Cannasoft is in the advanced stages of expanding its EZ-G device's applications into the leisure field of sex toys. In addition, the EZ-G device includes technological advancements as a sex toy with a more realistic experience.
Filing Patents for EZ-G
December 1, 2022
BYND Cannasoft announced the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design.
BYND Among Fastest-Growing Canna-Companies
November 30, 2022
BYND Cannasoft extended a small gain in October and is now up 75.3 percent in 2022Q4.
MEET THE BOARD
BYND Cannasoft Leadership
With a diverse and decorated team, it's no surprise that BYND Cannasoft Enterprises Inc. is on the verge of making some big moves.
Moti Maram
President, CEO
Harold Wolkin
Director
Yftah Ben Yaackov
CEO, Director
Dr. Stefania Szabo
Director
Avner Tal
VP of Sales/Marketing, Director
Niv Shirazi
Director
Disclaimer
Stock Research Today is a project of Virtus Media Group LLC and intended solely for entertainment and informational purposes. Consult your financial, investment and tax advisors to determine what financial and tax strategies may be right for you. Investor protection and other important information is available at https://www.sec.gov/. This website / media webpage is owned, operated and edited by Virtus Media LLC. Any wording found on this website / media webpage or disclaimer referencing “I” or “we” or “our” or “Virtus Media” refers to Virtus Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage .We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Virtus Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, sms, push notifications, influencers, social media postings, ticker tags, press releases, online interviews, podcasts, videos, audio ads, banner ads, native ads, responsive ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company's website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Virtus Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers' works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer's communications regarding the profiled company(s). You should assume all information in all of our communications in incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. Compensation: Pursuant to an agreement between Virtus Media LLC and Lifewater Media LLC, Virtus Media LLC has been hired for a period beginning on 10/24/22 and ending on 10/28/22 to publicly disseminate information about (NASDAQ: APCX) via digital communications. We have been paid twenty thousand USD via ACH Bank Transfer. Pursuant to an agreement between Virtus Media LLC and Social Media Outlet, Virtus Media LLC has hired Social Media Outlet for a period beginning on 10/24/22 and ending after five business days to publicly disseminate information about (NASDAQ: APCX) via digital communications. We have paid this Social Media Outlet five thousand USD via ACH Bank Transfer. Pursuant to an agreement between Virtus Media LLC and Social Media Outlet, Virtus Media LLC has hired Social Media Outlet for a period beginning on 10/24/22 and ending after five business days to publicly disseminate information about (NASDAQ: APCX) via digital communications. We have paid this Social Media Outlet five hundred USD via ACH Bank Transfer. Pursuant to an agreement between Virtus Media LLC and Social Media Outlet, Virtus Media LLC has hired Social Media Outlet for a period beginning on 10/24/22 and ending after five business days to publicly disseminate information about (NASDAQ: APCX) via digital communications. We have paid this Social Media Outlet two hundred ten USD via ACH Bank Transfer. Pursuant to an agreement between Virtus Media LLC and Lifewater media LLC, Virtus Media has been hired for a period beginning on 2023-04-24 and ending after 2023-04-26 to publicly disseminate information about NASDAQ: BCAN . We have been paid thirteen thousand five hundred dollars USD via ACH Bank Transfer.
